机译:高肿瘤渗透Foxp3(+)T细胞预测雌激素受体阳性乳腺癌存活率差:荟萃分析
Nanchang Univ Dept Gen Surg Affiliated Hosp 2 1 Minde Rd Nanchang 330006 Jiangxi Peoples R;
Nanchang Univ Dept Assisted Reprod Affiliated Hosp 1 Nanchang 330006 Jiangxi Peoples R China;
Nanchang Univ Dept Gen Surg Affiliated Hosp 2 1 Minde Rd Nanchang 330006 Jiangxi Peoples R;
Nanchang Univ Dept Assisted Reprod Affiliated Hosp 1 Nanchang 330006 Jiangxi Peoples R China;
First Affiliated Hosp Garman Med Dept Gen Surg Ganzhou 341000 Peoples R China;
Nanchang Univ Dept Operating Room Affiliated Hosp 2 Nanchang 330006 Jiangxi Peoples R China;
Nanchang Univ Dept Gen Surg Affiliated Hosp 2 1 Minde Rd Nanchang 330006 Jiangxi Peoples R;
Nanchang Univ Dept Gen Surg Affiliated Hosp 2 1 Minde Rd Nanchang 330006 Jiangxi Peoples R;
Nanchang Univ Dept Gen Surg Affiliated Hosp 2 1 Minde Rd Nanchang 330006 Jiangxi Peoples R;
FoxP3; Breast cancer; Prognostic; Estrogen receptor;
机译:高肿瘤渗透Foxp3(+)T细胞预测雌激素受体阳性乳腺癌存活率差:荟萃分析
机译:SNAI2上调与耐氟维司群的乳腺癌细胞的侵袭性表型有关,并且是雌激素受体阳性转移性乳腺癌对内分泌治疗反应不良的指标
机译:初级全身化疗后肿瘤渗透淋巴细胞预测雌激素受体阳性/海绵阴性乳腺癌预后差
机译:雌激素受体阳性乳腺癌:传统预测,分子病理:新的乳腺癌分类和21世纪个性化预测和预测测定
机译:胰岛素样生长因子1信号传导和雌激素受体之间的串扰:对乳腺癌细胞存活的影响。
机译:鉴定基质ColXα1和肿瘤浸润淋巴细胞作为雌激素受体阳性/ HER2阳性乳腺癌新辅助治疗的推定预测标志物
机译:鉴定基质ColXα1和肿瘤浸润淋巴细胞作为雌激素受体阳性/ HER2阳性乳腺癌新辅助治疗的推定预测标志物